Automated Precision Inc. (API) is a world leader in coordinate measurement solutions. Leading the metrology industry through innovation, API products are used by many of the world’s top automotive, aerospace, machine tool, and CMM manufacturers.

API’s technology improves production processes, from design and innovation to production, quality checks and inspections. The company offers dimensional inspection and metrology services, including consulting, calibration, machine tool error mapping, contract measurement, 3D CAD modeling and reverse engineering to solve difficult measurement problems.

Martek (now part of Royal DSM) was a leader in the innovation, development, production and sale of high-value products from microbial sources that promote health and wellness through nutrition. Martek’s technology platform consised of its core expertise, broad experience and proprietary technology in areas such as microbial biology, algal genomics, fermentation and downstream processing. This technology platform resulted in Martek’s development of a number of products, including the company’s flagship product, life’sDHA™, a sustainable and vegetarian source of algal DHA (docosahexaenoic acid) important for brain, heart and eye health throughout life—for use in infant formula, pregnancy and nursing products, foods and beverages, dietary supplements and animal feeds. Martek also produced life’sARA™ (arachidonic acid), an omega-6 fatty acid, for use in infant formula and follow-on formulas.

Northrop Grumman Corporation offers an extraordinary portfolio of capabilities and technologies that enable the company to deliver innovative systems and solutions for applications that range from undersea to outer space and into cyberspace.

The company’s core competencies address emerging global security challenges in key areas, such as unmanned systems, cybersecurity, C4ISR, and logistics that are critical to the defense of the nation and its allies.

MedImmune is the global biologics research and development arm of AstraZeneca, a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of small molecule and biologic prescription medicines. MedImmune is pioneering innovative research and exploring novel pathways across Oncology, Respiratory, Cardiovascular & Metabolic Diseases, and Infection and Vaccines. MedImmune is headquartered in Gaithersburg, Md., one of AstraZeneca’s three global R&D centers, with additional sites in Cambridge, UK and Mountain View, Calif.

MedImmune’s SYNAGIS therapeutic is an FDA-approved prescription injection of antibodies that is given monthly to help protect high-risk infants from severe respiratory syncytial virus, or RSV.

RSV is a common virus that, like the flu, is seasonal and easily spread. Most children will get RSV by the age of two. RSV begins with cold-like symptoms but can spread to the lungs. For babies with certain health conditions, RSV can be very serious.

SYNAGIS is the first monoclonal antibody approved for the prevention of an infectious disease, as well as the first such drug to be safely used in children.

dlhBowles is a company that combines engineering with best manufacturing practices to provide the world’s leading automakers with fluid management systems. Formerly Bowles Fluidics Corporation, the company formally changed its name in 2016, when it was acquired by Morgenthaler Private Equity, and merged with DLH Industries.